Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients

Hansol LeeMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;The University of Sydney Central Clinical School, Sydney, NSW, Australia

http://orcid.org/0000-0002-6270-1203 View further author information

Camelia QuekMelanoma Institute Australia, The University of Sydney, Sydney, NSW, AustraliaView further author information

Ines SilvaMelanoma Institute Australia, The University of Sydney, Sydney, NSW, AustraliaView further author information

Annie TaskerMelanoma Institute Australia, The University of Sydney, Sydney, NSW, AustraliaView further author information

Marcel BattenMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;The University of Sydney Central Clinical School, Sydney, NSW, AustraliaView further author information

Helen RizosFaculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, AustraliaView further author information

Su Yin LimFaculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, AustraliaView further author information

Tuba Nur GideMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;The University of Sydney Central Clinical School, Sydney, NSW, AustraliaView further author information

Ping ShangMelanoma Institute Australia, The University of Sydney, Sydney, NSW, AustraliaView further author information

Grace H. AttrillMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;The University of Sydney Central Clinical School, Sydney, NSW, AustraliaView further author information

Jason MadoreMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;The University of Sydney Central Clinical School, Sydney, NSW, AustraliaView further author information

Jarem EdwardsMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;The University of Sydney Central Clinical School, Sydney, NSW, AustraliaView further author information

Matteo S. CarlinoMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, NSW, AustraliaView further author information

Alexander GuminskiMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, AustraliaView further author information

Robyn P.M. SawMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaView further author information

John F. ThompsonMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaView further author information

Peter M. FergusonMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaView further author information

Umaimainthan PalendiraDiscipline of Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, NSW, AustraliaView further author information

Alexander M. MenziesMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, AustraliaView further author information

Georgina V. LongMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia

http://orcid.org/0000-0001-8894-3545 View further author information

Richard A. ScolyerMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;The University of Sydney Central Clinical School, Sydney, NSW, Australia;Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaView further author information

James S. WilmottMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;The University of Sydney Central Clinical School, Sydney, NSW, AustraliaCorrespondence[email protected]

http://orcid.org/0000-0002-6750-5244 View further author information

show all

Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients

Articles from other publishers (43)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients

Citations (46)

Read on this site (3)

Articles from other publishers (43)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date